Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Fish and Richardson
Colorcon
Healthtrust
Citi
Harvard Business School
Argus Health
Farmers Insurance
Chubb

Generated: January 18, 2018

DrugPatentWatch Database Preview

EXIDINE Drug Profile

« Back to Dashboard

Which patents cover Exidine, and when can generic versions of Exidine launch?

Exidine is a drug marketed by Xttrium and is included in four NDAs.

The generic ingredient in EXIDINE is chlorhexidine gluconate. There are fifty-seven drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Drug patent expirations by year for EXIDINE
Pharmacology for EXIDINE
Physiological EffectDecreased Cell Wall Integrity
Medical Subject Heading (MeSH) Categories for EXIDINE

US Patents and Regulatory Information for EXIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xttrium EXIDINE chlorhexidine gluconate AEROSOL, METERED;TOPICAL 019127-001 Dec 24, 1984 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Xttrium EXIDINE chlorhexidine gluconate SOLUTION;TOPICAL 019125-001 Dec 24, 1984 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Xttrium EXIDINE chlorhexidine gluconate SOLUTION;TOPICAL 019422-001 Dec 17, 1985 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Xttrium EXIDINE chlorhexidine gluconate SOLUTION;TOPICAL 019421-001 Dec 17, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Chubb
QuintilesIMS
Moodys
Federal Trade Commission
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot